Gland Pharma

Price chart

Previous close

₹3,132.80

Open

₹3,166.80

Day high

₹3,374.00

Day low

₹3,140.80

Listed on NSE since 20 November 2020.

Market value

₹52,297 Cr

P/E (trailing)

42.29

EPS (trailing)

₹74.95

Price to book

5.04

Dividend yield

0.63%

Debt to equity

0.03

Profit margin

16.8%

Beta

0.52

Volume today

18.93 L

Average volume

6.19 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Gland Pharma’s results filed with NSE, consolidated (the whole group). Net profit is the share of Gland Pharma’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Gland Pharma’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company also offers its products for various therapeutic categories, such as anti- diabetic, anti-malarial, anti-infectives, anti-neoplastic, and neurological and central nervous system; blood related, ophthalmics and otologicals, cardiac, gastro-intestinal, and hormonal products; pain, neuromuscular blocking agents, and analgesics; respiratory and pulmonology; and vitamins, minerals, and nutrients. In addition, it provides contract development, dossier preparation, and technology transfer services. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Hyderabad

Employees

4,332

Company website · Profile: Yahoo Finance

• Gland Pharma shares jump 4% after Q2 profit jumps 58%, revenue rises 23% YoY

  The Economic Times · 9 Nov, 10:56

• Gland Pharma shares hit 52-week high; jump 7% despite market sell-off | Will rally continue after 93% YTD rise?

  Mint · 9 Nov, 10:19

• Q2 Results Highlights: Hindalco Q2 profit zooms, Voltas up 51%, Aster DM, Gland Pharma surge 58%, Siemens grows 5%; Bosch, Coromandel, Honasa profit down

  BusinessLine · 6 Nov, 21:39

• Gland Pharma Q2FY27 results: Net profit rises 58% to ₹290.75 crore

  Business Standard · 6 Nov, 20:17

• Gland Pharma Q2 Results: Net profit jumps 58% on strong business execution, CDMO revenue up 31%

  CNBC-TV18 · 6 Nov, 17:44

• Dividend - Rs 20 Per Sh

  Dividend · ex-date 11 August 2026

• Dividend - Rs 18 Per Share

  Dividend · ex-date 14 August 2025

• Annual General Meeting/Dividend - Rs 20 Per Share

  Dividend · ex-date 16 August 2024

• Annual General Meeting

  Action · ex-date 6 August 2021

Source: NSE. Latest first.